Orchid is pleased with this result and will continue to protect its approved ANDAs for its Piperacillin and Tazobactam for Injections and also continue to supply the products to its distribution partner, Apotex Corp., for marketing and distribution in the US.
The company made this announcement during the trading hours today, 25 September 2009.